​

Aura Biosciences Ownership | Who Owns Aura Biosciences?

OverviewForecastFinancialsChart

Aura Biosciences Ownership Summary

Aura Biosciences is owned by 13.49% institutional investors, 1.01% insiders, and 85.50% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 11.47% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAura Biosciences13.49%1.01%85.50%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M11.47%$46.31M
Frazier life sciences management5.10M8.45%$34.12M
Adage capital partners gp4.88M8.09%$32.65M
Long focus capital management4.62M7.66%$30.91M
Suvretta capital management4.37M7.25%$29.25M
Blackrock3.01M6.08%$22.72M
Blackrock funding, inc. /de3.59M5.94%$23.99M
Medicxi ventures management (jersey)3.04M5.04%$20.34M
Vanguard group2.94M4.45%$16.00M
Nantahala capital management2.12M3.51%$14.17M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Matrix capital management company, lp6.92M100.00%$46.31M
B group597.58K2.96%$4.00M
Medicxi ventures management (jersey)3.04M2.07%$20.34M
Regency capital management inc.\de532.50K1.59%$3.56M
Acorn capital advisors595.74K1.13%$3.99M
Frazier life sciences management5.10M0.88%$34.12M
Long focus capital management4.62M0.81%$30.91M
Suvretta capital management4.37M0.75%$29.25M
Nantahala capital management2.12M0.52%$14.17M
Levin capital strategies941.40K0.48%$6.30M

Top Buyers

HolderShares% AssetsChange
Blackrock3.01M0.00%560.52K
Balyasny asset management557.65K0.00%557.65K
Millennium management1.10M0.00%480.29K
Vanguard fiduciary trust397.16K0.00%397.16K
Caligan partners lp229.86K0.10%229.86K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---4.08M
Samsara biocapital584.85K0.47%-415.15K
Ensign peak advisors---390.69K
Decheng capital---360.48K
Jefferies financial group---222.50K

New Positions

HolderShares% AssetsChangeValue
Balyasny asset management557.65K0.00%557.65K$3.73M
Vanguard fiduciary trust397.16K0.00%397.16K$2.66M
Fisher asset management83.51K0.00%83.51K$558.67K
Maven securities50.00K0.01%50.00K$334.50K
Vanguard global advisers39.79K0.00%39.79K$266.19K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Capital performance advisors llp-25.00
Corecap advisors-33.00
Nisa investment advisors-36.00
Coldstream capital management-40.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202653-54.31%8,140,896-83.79%130.23%29-44.23%15-60.53%
Dec 31, 202576-28.30%32,618,162-36.85%490.62%32-40.74%2827.27%
Sep 30, 20251037.29%51,053,7131.75%871.18%53-1.85%21-25.00%
Jun 30, 20251018.60%50,603,53553.66%872.02%5732.56%29-3.33%
Mar 31, 202594-3.09%39,855,4091.03%791.26%43-27.12%3076.47%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
Vanguard Total Stock Mkt Idx Inv1.55M2.42%-
Franklin Biotechnology Discv A(acc)USD1.31M2.04%-
iShares Russell 2000 ETF1.04M1.63%8.74K
Franklin Biotechnology Discovery A765.62K1.19%-
Vanguard Institutional Extnd Mkt Idx Tr640.71K1.00%5.70K
Fidelity Small Cap Index429.43K0.67%-1.74K
iShares Biotechnology ETF333.21K0.52%2.11K
Fidelity Extended Market Index312.12K0.49%11.35K
State St Russell Sm/Mid Cp® Indx SL Cl I254.34K0.40%-

Recent Insider Transactions

DateNameRoleActivityValue
May 07, 2026Matrix Capital Management Company, LP-Sell$39.04M
Apr 16, 2026Kilroy Conor See RemarksSell$82.40K
Feb 17, 2026Kilroy Conor See RemarksSell$61.00K
Feb 17, 2026Plavsic Mark Chief Technology OfficerSell$80.24K
Feb 17, 2026Hopkins Janet Jill Chief Medical OfficerSell$103.23K

Insider Transactions Trends

DateBuySell
2026 Q2-2
2026 Q1-7
2025 Q4-4
2025 Q3-1
2025 Q243

AURA Ownership FAQ

Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 13.49%, followed by 1.01% insiders and 85.50% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 35.75%, which Aura Biosciences falls below.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 11.47%), Frazier life sciences management (5.1M shares, 8.45%), and Adage capital partners gp (4.88M shares, 8.09%). Together, they hold 28.02% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Matrix capital management company, lp is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 6.92M Aura Biosciences shares, valued at 46.31M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools